IceCure Medical Ltd (ICCM)
NASDAQ: ICCM · Real-Time Price · USD
1.235
-0.005 (-0.38%)
Apr 2, 2025, 2:43 PM EDT - Market open

IceCure Medical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-15.32-14.65-16.98-9.9-3.73
Upgrade
Depreciation & Amortization
0.330.320.250.130.06
Upgrade
Stock-Based Compensation
0.871.311.870.320.23
Upgrade
Other Operating Activities
0.04-0.050.360.01-0.45
Upgrade
Change in Accounts Receivable
-0.12-0.030.38-0.36-0.08
Upgrade
Change in Inventory
0.290.58-0.9-0.89-0.39
Upgrade
Change in Accounts Payable
0.73-0.21-0.170.240.22
Upgrade
Change in Other Net Operating Assets
0.620.180.91-2.140.45
Upgrade
Operating Cash Flow
-12.56-12.55-14.29-12.61-3.69
Upgrade
Capital Expenditures
-0.07-0.48-0.89-0.53-0.22
Upgrade
Investment in Securities
0.53-0.5-4.62-4.43
Upgrade
Other Investing Activities
-0.010.3--0.3-0.02
Upgrade
Investing Cash Flow
0.45-0.68-0.893.79-4.67
Upgrade
Issuance of Common Stock
9.670.0814.5127.746.08
Upgrade
Other Financing Activities
-0.49--0.933.15-0.22
Upgrade
Financing Cash Flow
9.190.0813.5830.895.86
Upgrade
Foreign Exchange Rate Adjustments
-0.040.03-0.360.040.22
Upgrade
Net Cash Flow
-2.97-13.13-1.9622.12-2.29
Upgrade
Free Cash Flow
-12.63-13.03-15.18-13.14-3.91
Upgrade
Free Cash Flow Margin
-383.89%-403.53%-492.16%-317.50%-101.16%
Upgrade
Free Cash Flow Per Share
-0.25-0.29-0.41-0.46-0.23
Upgrade
Levered Free Cash Flow
-7.18-7.75-8.79-9.26-2.99
Upgrade
Unlevered Free Cash Flow
-7.18-7.75-8.64-9.15-2.99
Upgrade
Change in Net Working Capital
-1.5-0.83-0.62.990.47
Upgrade
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q